HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of 5-fluorouracil in combination with methoxyphenyl maleamic acid in murine tumors.

Abstract
Combination chemotherapy studies were carried out in vivo against sarcoma 180 (ascites)(S180) and Ehrlich (ascites) carcinoma (EAC) tumours using cytotoxic drugs and methoxyphenyl maleamic acid (MPMA), an intermediate in the synthesis of pyrrolidine-nitrogen-mustards. Preliminary data have suggested that the combination of 5-fluorouracil (5-FU) and methoxyphenyl maleamic acid (MPMA) was more active than 5-FU used singly against EAC tumour. The possible therapeutic potential of this combination was further investigated in EAC tumour.
AuthorsM A Indap, R Y Ambaye
JournalJournal of postgraduate medicine (J Postgrad Med) Vol. 37 Issue 4 Pg. 211-5 (Oct 1991) ISSN: 0022-3859 [Print] India
PMID1841970 (Publication Type: Journal Article)
Chemical References
  • Maleates
  • Fluorouracil
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Ehrlich Tumor (drug therapy)
  • Drug Therapy, Combination
  • Female
  • Fluorouracil (administration & dosage)
  • Male
  • Maleates (administration & dosage)
  • Mice
  • Random Allocation
  • Sarcoma 180 (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: